Merged House Bill Seeks More Part D Savings, Broader Medicaid Expansion
Executive Summary
The health care reform bill unveiled by the House leadership Oct. 29 seeks increased drug savings for the Medicare Part D program through mandated rebates for products provided to low-income beneficiaries and by requiring HHS to negotiate drug pricing directly with manufacturers
You may also be interested in...
Many Blue Dogs Go Against House Bill Despite Concessions On Public Option
Blue Dog Democrats' "no" votes make House health reform vote a close one: Could more conservative Senate Finance Committee bill be ultimate template for reform?
Battle Over Part D Rebates Gets Tougher: AARP Endorses House Bill
The pharmaceutical industry's campaign against legislation mandating drug rebates for low-income beneficiaries covered by Medicare Part D has gotten more challenging
Battle Over Part D Rebates Gets Tougher: AARP Endorses House Bill
The pharmaceutical industry's campaign against legislation mandating drug rebates for low-income beneficiaries covered by Medicare Part D has gotten more challenging